Minister for Higher Education and Research Claude Meisch at the inauguration of the Clinnova project focusing on precision medicineArtificial intelligence (AI) has huge potential to enhance healthcare but its implementation faces challenges, notably in the context of data enabling and the ability to build appropriate clinical studies. The objective of the Clinnova project, which is supported by the Luxembourg National Research Fund (FNR), the Grand Est Region in France, the Swiss Canton of Basel and the German State of Baden-Württemberg, is to foster AI-driven precision medicine via data federation, standardization, and interoperability.

Advancing precision medicine

To date, there are no straightforward methods available to decide which drug to prescribe to which patient. With new drugs coming on the market in a steady flow, physicians and patients are faced with a concrete problem: the wrong therapy may aggravate the disease and incur unnecessary cost for the social system. Clinnova was conceived as a precision medicine initiative that tackles these challenges on three levels.

Clinnova primarily focuses on generating benefits for patients and physicians regarding three diseases: inflammatory bowel disease, rheumatoid diseases and multiple sclerosis. With an emphasis on data quality and standardisation, the goal is to develop effective AI algorithms that can support physicians in prescribing the right drug to an individual patient at the right time. Furthermore, these data can accelerate translational research into disease causes, which can further affect patient care.

We envision that in a data-enabled environment, the translation and application of biomedical research towards patients will become a seamless routine process.

Clinnova will also bridge the worlds of biomedical research and healthcare by fostering critical infrastructure development in Luxembourg. It will undertake the necessary steps to assure data interoperability and integration in this infrastructure concept.

Finally, Clinnova will federate precision health data across borders. The Clinnova team in Luxembourg has teamed up with universities and clinical centres in Baden-Württemberg in Germany, the Grand Est region in France, and the region of Basel in Switzerland to invest in similar Clinnova precision health programmes and link the IT infrastructures set up. The Clinnova partners are thus building a federated precision health network across Europe.

Artificial intelligence solutions for healthcare

Overall, AI-driven solutions for healthcare require both infrastructure investment and coordination between clinical institutions. “We envision that in such a data-enabled environment, the translation and application of biomedical research towards patients and their unmet needs will become a seamless routine process,” says Dr Jasmin Schulz, chief coordinator of Clinnova at the Luxembourg Institute of Health. The project’s stakeholders also believe that translational research initiatives focused on patients will evolve to become a major driver for fundamental research, thereby increasing the amount of therapeutic possibilities for patients in the future.

Clinnova will significantly contribute to Luxembourg’s research environment and the expansion of its positive image throughout the world.

“By leveraging data federation, standardisation and interoperability, Clinnova is poised to foster AI-driven precision medicine at an unprecedented scale,” comments Claude Meisch, Minister of Higher Education and Research. “By utilising international and interdisciplinary expertise anchored within the national priority of personalised healthcare, the project fully aligns with the Luxembourg National Research and Innovation Strategy. Clinnova will significantly contribute to Luxembourg’s research environment and the expansion of its positive image throughout the world.”

Photo credits: Luxembourg Institute of Health

Read more

Webasto invests in new production line in Luxembourg


Automotive supplier Webasto has been present in Luxembourg since summer 2022 and is turning the facility here into its global centre of competence for smart glazing. The company is now investing in a new Luxembourg-based production line for high-tech glass. The ground-breaking ceremony was held on 24 May 2023.
Read more

House of Sustainability opens in Luxembourg


The House of Sustainability, which officially launched on 21 April 2023 as a one-stop shop for all sustainable development solutions in Luxembourg, offers and guides companies toward an all-inclusive service offering available in Luxembourg to support their sustainable transition. Companies of all sizes and from all sectors can benefit from a vast ecosystem of sustainable solution providers based in Luxembourg.
Read more

Two Luxembourg start-ups supported by WomenTechEU


In the framework of the WomenTechEU programme dedicated to innovative deep-tech projects led by women, two Luxembourg companies, supported by Luxinnovation, have received European financial aid.
Read more

Luxembourg: Exceptionally open to business


In April 2023, Adrian Trömel, Luxembourg’s Foreign Trade Advisor in Texas, co-organised a visit to Luxembourg for a group of Houston-based venture capital, private equity and real estate firms to explore how the Grand Duchy could help them reach the European market. The similar economic interests, including Luxembourg’s openness to business, services and resources for funds and companies looking to grow left a lasting impression on the delegation.
Read more

Innovative companies in Luxembourg are supported by “a strong network”


Maxime Delmée, Belgian CEO and co-founder of AM 4 AM, a startup specialised in the development of new materials for additive manufacturing and a graduate of the Fit 4 Start acceleration programme in Luxembourg, discusses his entrepreneurial experience in Luxembourg. He explains that Luxembourg’s openness to innovation and its support for startups was crucial to his company’s development.
Read more

Resources all news